Product category:
Genomics
News Release from: Cambridge BioScience | Subject: Cytofectin
Edited by the Laboratorytalk Editorial
Team on 02 April 2003
Transfection reagent for antisense
oligos
Delivers oligonucleotides efficiently into a broad spectrum of cell lines and alleviates two problems commonly associated with lipid-mediated delivery of antisense oligos
Cambridge BioScience has added Cytofectin transfection reagent for antisense oligonucleotides from Gene Therapy Systems to its range of gene delivery products Cytofectin transfection reagent delivers oligonucleotides efficiently into a broad spectrum of cell lines and alleviates the two problems commonly associated with lipid-mediated delivery of antisense oligos - poor transfection efficiency and high levels of cytotoxicity
This article was originally published on Laboratorytalk on 4 Jul 2005 at 8.00am (UK)
Related stories
Monoclonal antibody to mouse IPC
Inhibitory antibody reacts with a cell-surface molecule selectively expressed on mouse inteferon producing cells
Cytofectin transfection reagent has been functionally tested in diverse human and animal cell types and is compatible with both serum-containing and serum-free media.
Its high efficiency for antisense oligonucleotides has been proven in a variety of studies.
Cambridge BioScience is the sole UK distributor of Cytofectin transfection reagent.
With this reagent, and the Gene Silencer siRNA Transfection Reagent, also from Gene Therapy Systems, Cambridge BioScience offers the best transfection reagent collection on the market for gene knockdown, ie, the alteration of a gene so that it may be expressed conditionally.
These products are available from Cambridge BioScience in the UK and Ireland only.
• Cambridge BioScience: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
